Skip Viragh Center for Pancreatic Cancer
Tracked across 1 events · 21 articles · First seen Jul 16, 2026 · Last active Aug 07, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
A phase 1 clinical trial of mKRAS-VAX, an investigational vaccine targeting six common KRAS mutations, demonstrated safety and durable immune responses in 18 of 20 high-risk individuals for pancreatic ductal adenocarcinoma (PDAC). The vaccine, developed…
Impact: Co-directed by Elizabeth Jaffee; supports pancreatic cancer research and may benefit from the vaccine's success.
Jul 16, 2026 · 21 articles
ERGEN INTELLIGENCE
Track Skip Viragh Center for Pancreatic Cancer live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard